Peter Shane Hamblin

21PUBLICATIONS
40CO-AUTHORS
Business analyticsMajor global burdens of diseaseFinancial accountingFood properties (incl. characteristics and health benefits)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 29, 2026
Shifts in Incident Glucose Lowering Drug Initiation in Type 2 Diabetes From 2014 to 2024: A Population-Based Study.

|May 29, 2026
Sustainability of an electronic technology-based intervention in general practice targeting improved detection and monitoring of the interrelated chronic vascular diseases.

|Dec 29, 2025
Comparative effectiveness of glucose monitoring methods and glycaemic control in patients with type 2 diabetes: An umbrella review.

Nathaniel Foo, Sri Chodapaneedi, Brayden Gibson

|Sep 02, 2024
Utilization and cost of non-insulin glucose-lowering drugs in Australia from 2013 to 2023.

Peter S Hamblin, Arul Earnest, Anthony W Russell

|Oct 09, 2023
Systemic and iatrogenic factors contribute to the development of severe hypernatraemia in vulnerable inpatients.

Esha Kathpal, Emma Boehm, Christopher S Nguyen

|Jan 04, 2023
Participants' and Health Care Providers' Insights Regarding a Web-Based and Mobile-Delivered Healthy Eating Program for Disadvantaged People With Type 2 Diabetes: Descriptive Qualitative Study.

Nazgol Karimi, Rachelle Opie, David Crawford

Pageof 4

Frequent Collaborators

4 joint publications

Elif I Ekinci

3 joint publications

Leon A Bach

3 joint publications

Sophia Zoungas

3 joint publications

Stella Talic